More on Medifast (MED): Q3 beats across the board on strong sales momentum across all units....
More on Medifast (MED): Q3 beats across the board on strong sales momentum across all units. Total sales were up nearly 20% Y/Y, while bottom-line results were boosted by better operating efficiencies and lower expenses. Shares +5.5% AH.
From other sites
at CNBC.com (Oct 27, 2014)
at CNBC.com (Jan 7, 2013)
at CNBC.com (Jul 27, 2012)
at CNBC.com (Mar 3, 2011)
at CNBC.com (Dec 20, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs